Find uplifting stories about heroes, innovations, and solutions
170 results for "immunotherapy"
Researchers discovered that cancer's favorite hiding trick might actually make tumors vulnerable to a different immune attack. The finding challenges decades of immunology rules and could reshape cancer treatment.
Researchers discovered how to supercharge immune cells used in cancer treatment by turning off a single gene, making them fight tumors longer and stronger. The breakthrough could help millions of patients whose cancers don't respond to current therapies.
A $50,000 grant is helping Canadian researchers unlock why the deadliest brain cancer resists treatment that works for other cancers. The early-stage work could lead to the first effective immunotherapy for glioblastoma patients.
Scientists at McGill University have discovered how to dramatically boost natural killer cells to attack aggressive cancers that resist standard treatments. The breakthrough could offer hope to patients with limited options while avoiding the risks of permanent genetic modification.
Scientists are testing vaccines that could stop cancer before it starts, marking a shift from treatment to prevention. The breakthrough builds on 15 years of immune therapy progress that's already saved thousands of lives.
Breakthrough vaccines and treatments are dramatically reducing HPV-related cancers that affect millions worldwide. Scientists now have powerful new tools to prevent and treat cervical, throat, and other cancers caused by the virus.
A drug used for decades to treat asthma could help patients beat tough cancers that resist treatment. Northwestern University researchers discovered how tumors hijack immune cells and found an existing medication can stop them.
A Maryland mother of two is cancer-free one year after receiving a newly approved treatment that uses cells from her own tumor to fight back. Her story offers hope to patients who thought they'd run out of options.
A new combination drug therapy reduced lung cancer progression by 65% in a groundbreaking study, offering fresh hope for patients facing this deadly disease. The treatment marks the first successful pairing of two powerful cancer-fighting approaches in previously untreated patients.
A common asthma medication could help hard-to-treat cancers like triple-negative breast cancer respond to immunotherapy. Scientists discovered the drug reverses immune cells that tumors hijack to resist treatment.
A groundbreaking $4 million clinical trial in Canada is pairing gut bacteria capsules with immunotherapy to help lung cancer patients who aren't responding to standard treatments. If successful, the LUNA-2 trial could extend lives and reduce side effects for thousands of Canadians.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
Scientists at Baylor University are pioneering breakthrough treatments for kidney, pancreatic, breast, and colorectal cancers using tumor starvation, natural products, and modified bacteria. Their innovative approaches could transform outcomes for patients facing some of the deadliest forms of cancer.
A new immunotherapy that helps the immune system fight stomach cancer is now available in England after a record-fast approval. More than 1,500 people each year could benefit from the treatment that significantly improves survival rates.
After decades of careful sun protection, Sherry O'Daniell was devastated to learn childhood sun exposure had given her stage 3 melanoma. Thanks to new immunotherapy treatment, she's now cancer-free and sharing her story to help others.
)
A simple daily capsule is helping melanoma patients who stopped responding to cancer treatment, offering new hope where options ran out. The gut-friendly therapy passed its first major safety test across four countries.
A new immunotherapy drug for aggressive stomach cancer just got the green light from the NHS, marking the first major treatment breakthrough in nearly ten years. About 1,500 people a year in the UK will now have access to a therapy that extends survival and reduces cancer recurrence.
A personalized vaccine safely triggered immune responses in patients with glioblastoma, one of the most aggressive brain cancers. The early trial offers fresh hope for a disease that typically gives patients less than 18 months to live.
Scientists discovered that making cancer cells physically stiffer dramatically improved CAR T-cell therapy results in mice with severe skin cancer. This breakthrough could help save more lives by making one of medicine's most promising cancer treatments even more effective.
Around 1,500 people with stomach cancer will gain access to a groundbreaking immunotherapy treatment that extends survival and reduces recurrence. It's the first major advance in stomach cancer care in nearly ten years.
Showing 20 of 170